Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Great Place To Work unveils Top 10 Best Workplaces in Singapore Healthcare and Biopharma™ 2024 2024-04-03 12:00
RemeGen's Telitacicept (RC18) Granted Fast Track Designation by United States FDA for Treatment of Primary Sjögren's Syndrome 2024-04-03 11:14
CONCEPT MEDICAL RECEIVES US FDA IDE APPROVAL FOR MAGICTOUCH AVF INDICATION, THEIR FIFTH US CLINICAL STUDY APPROVAL FOR THE MAGICTOUCH PORTFOLIO 2024-04-02 17:33
European Wellness Shines at AMWC 2024 in Monaco, with Prof. Dr Mike Chan and Prof. Dr Roni Moya as Faculty's Stem Cells Speakers 2024-04-02 14:16
Innovent and HUTCHMED Jointly Announce NDA Acceptance in China for Sintilimab Combination with Fruquintinib for the Treatment of Advanced Endometrial Cancer with Priority Review Status 2024-04-02 13:00
Fosun International: Total Revenue for 2023 Reached RMB198.2 billion, Industrial Operation Profit Increased by 20% YoY 2024-04-02 11:31
Kemwell BioPharma Drives Quality Excellence with Veeva Vault QMS 2024-04-02 10:30
Oncoclínicas&Co has revenues of R$6 billion and profit of R$313 million in 2023 2024-04-02 00:38
ThinkCyte advances biopharma phenotypic drug discovery programs with publication and presentation milestones 2024-04-01 21:00
Novel Immunogenicity Risk Assessment Platform, ISPRI, Facilitates Biologic Therapeutics Development 2024-04-01 20:00
Hyosung TNC Invests $1 Billion in Future "Bio" Business 2024-04-01 08:18
Alphamab Oncology Reports Full Year 2023 Financial Results and Business Highlights 2024-03-29 10:42
Viva Biotech (1873.HK) Announces 2023 Annual Results: Successful Implementation of Light-asset Strategy, Achieving Solid Growth and Promising Future 2024-03-28 22:46
Broncus Medical (02216.HK) Announces Annual Results for 2023 2024-03-28 22:32
Sirnaomics Announces 2023 Annual Results 2024-03-28 17:09
Recbio And Rongsheng Biotech Signed a Strategic Cooperation Agreement On The New Adjuvant Vaccine Project 2024-03-27 11:24
Innovent Dosed First Participant in Phase 3 Clinical Study (Neoshot) of IBI310 (Anti-CTLA-4 Monoclonal Antibody) in Combination with Sintilimab for MSI-H/dMMR Colon Cancer Neoadjuvant Therapy 2024-03-27 08:00
World First Use of Lightpoint's SENSEI® Drop-In Gamma Probe in Bladder Cancer Surgery Performed in Spain 2024-03-27 05:59
ReportLinker Reveals Key Insights About Players and Coverage in Latest Combination Vaccine Market Analysis 2024-03-26 21:00
Alphamab Oncology Announces the First Patient Dosed in Australia in the Clinical Study of Subcutaneous Formulation JSKN033 2024-03-26 09:57
1 2 3 4 5 6 211